NEW YORK (GenomeWeb) – Singapore-based Clearbridge Biomedics and Germany-based Leica Biosystems (LBS) have partnered to comarket each other's products in order support research on circulating tumor cells.

The companies will comarket Clearbridge's ClearCell CTC enrichment system and LBS' Bond Rx staining platform, creating an integrated and automated workflow for CTC enrichment and immunostaining.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.